Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use KEVZARA® safely and effectively. See full prescribing information for KEVZARA. KEVZARA (sarilumab) injection, for subcutaneous use Initial U.S. Approval: 2017
Medication labelWhy this: Advisory · dailymed-prescription
KEVZARA® is indicated for treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to one or more disease-modifying antirheumatic drugs (DMARDs). KEVZARA is indicated for treatment of adult patients with polymyalgia rheumatica who have had an inadequate response to corticosteroids or who cannot tolerate corticosteroid taper. KEVZARA is indicated for treatment of active polyarticular juvenile idiopathic arthritis (pJIA) in patients who weigh 63 kg or greater.
- generic_name
- sarilumab
- product_names
- sarilumab
- ndc
- 0024-5908, 0024-5910, 0024-5920, 0024-5922, 0024-5908-00, 0024-5908-01, 0024-5908-02, 0024-5910-00, 0024-5910-01, 0024-5910-02, 0024-5920-00, 0024-5920-01, 0024-5920-02, 0024-5922-00, 0024-5922-01, 0024-5922-02
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en